TD Private Client Wealth LLC Has $294,000 Stake in Agilent Technologies, Inc. $A

TD Private Client Wealth LLC decreased its position in Agilent Technologies, Inc. (NYSE:A) by 37.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,494 shares of the medical research company’s stock after selling 1,502 shares during the period. TD Private Client Wealth LLC’s holdings in Agilent Technologies were worth $294,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Valeo Financial Advisors LLC increased its stake in Agilent Technologies by 3.0% in the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 102 shares in the last quarter. Cary Street Partners Financial LLC increased its stake in Agilent Technologies by 2.9% in the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares in the last quarter. Western Pacific Wealth Management LP increased its stake in Agilent Technologies by 15.2% in the first quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company’s stock valued at $102,000 after purchasing an additional 115 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in Agilent Technologies by 5.1% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company’s stock valued at $281,000 after purchasing an additional 116 shares in the last quarter. Finally, Brighton Jones LLC increased its stake in Agilent Technologies by 2.6% in the first quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company’s stock valued at $560,000 after purchasing an additional 121 shares in the last quarter.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the company’s stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares of the company’s stock, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Agilent Technologies Trading Up 1.3%

Shares of A stock opened at $123.45 on Monday. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The company has a 50-day simple moving average of $121.15 and a two-hundred day simple moving average of $115.91. The company has a market capitalization of $35.00 billion, a price-to-earnings ratio of 28.98, a PEG ratio of 4.03 and a beta of 1.24.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the firm posted $1.32 EPS. The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is presently 23.24%.

Wall Street Analyst Weigh In

Several research firms have weighed in on A. Robert W. Baird lifted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Evercore ISI decreased their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating for the company in a research note on Thursday, August 28th. Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Monday, September 15th. Barclays reaffirmed an “equal weight” rating and issued a $125.00 price target on shares of Agilent Technologies in a research note on Friday, August 29th. Finally, Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $140.08.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.